Literature DB >> 31435023

Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia.

Yishai Ofran1,2, Shimrit Ringelstein-Harlev3,4, Ilana Slouzkey5, Tsila Zuckerman3,4, Dana Yehudai-Ofir3, Israel Henig3, Ofrat Beyar-Katz3, Michal Hayun3, Avraham Frisch3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31435023     DOI： 10.1038/s41375-019-0548-z

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

Review 1.  CAR T cells for other pediatric non-B-cell hematologic malignancies.

Authors:  Adam J Lamble; Rebecca Gardner
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

2.  MRD in adult Ph/BCR-ABL-negative ALL: how best to eradicate?

Authors:  Nicola Gökbuget
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 3.  T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies.

Authors:  Valentina Cordo'; Jordy C G van der Zwet; Kirsten Canté-Barrett; Rob Pieters; Jules P P Meijerink
Journal:  Blood Cancer Discov       Date:  2020-11-24

Review 4.  MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL.

Authors:  Manuela Tosi; Orietta Spinelli; Matteo Leoncin; Roberta Cavagna; Chiara Pavoni; Federico Lussana; Tamara Intermesoli; Luca Frison; Giulia Perali; Francesca Carobolante; Piera Viero; Cristina Skert; Alessandro Rambaldi; Renato Bassan
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

Review 5.  Lymphoblastic Lymphoma: a Concise Review.

Authors:  Tamara Intermesoli; Alessandra Weber; Matteo Leoncin; Luca Frison; Cristina Skert; Renato Bassan
Journal:  Curr Oncol Rep       Date:  2022-01-20       Impact factor: 5.075

Review 6.  Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia.

Authors:  Agata Pastorczak; Krzysztof Domka; Klaudyna Fidyt; Martyna Poprzeczko; Malgorzata Firczuk
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

Review 7.  The Circular Life of Human CD38: From Basic Science to Clinics and Back.

Authors:  Alberto L Horenstein; Angelo C Faini; Fabio Morandi; Cristiano Bracci; Francesco Lanza; Nicola Giuliani; Aneel Paulus; Fabio Malavasi
Journal:  Molecules       Date:  2020-10-21       Impact factor: 4.411

Review 8.  Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia.

Authors:  Fátima Bayón-Calderón; María L Toribio; Sara González-García
Journal:  Int J Mol Sci       Date:  2020-10-16       Impact factor: 5.923

9.  Salvage Therapy in Early Relapse of T-Lymphoblastic Leukemia/Lymphoma Using Daratumumab/Nelarabine Combination: Two Consecutive Cases.

Authors:  Ingolf Molle; Irma Petruskevicius; Peter Kamper; Francesco d'Amore
Journal:  Case Rep Hematol       Date:  2022-01-10

10.  Daratumumab: new indications revolving around "off-targets".

Authors:  Yishai Ofran
Journal:  Haematologica       Date:  2021-12-01       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.